IN.gov - Skip Navigation

Note: This message is displayed if (1) your browser is not standards-compliant or (2) you have you disabled CSS. Read our Policies for more information.

Indiana Professional Licensing Agency

PLA > Professions > Medical Licensing Board of Indiana Medical Licensing Board of Indiana


Professional Licensing Agency
Attn: Medical Licensing Board of Indiana
402 W. Washington Street, Room W072
Indianapolis, Indiana 46204

Board Director
Michael Minglin, J.D.

Assistant Director
Jody Edens

Litigation Specialist
Donna Moran

Customer Service Representatives
Meredith Shirley
Dawn Shaffer
Elizabeth Sangar
Daniel Bridgeman
Jerry Hellman

   Staff Phone Number: 317-234-2060
Staff E-mail:
pla3@pla.IN.gov

Rulemaking Docket for LSA#14-289
Requirements for Prescribing Opioid Controlled Substances for Pain Management

Subject Matter
                                  P.L. 185-2013 (SEA 246) requires the Medical Licensing Board to adopt permanent rules under IC 4-22-2 to establish standards and protocols for the prescribing of controlled substances before November 1, 2014.

Notice of Intent
http://www.in.gov/legislative/iac/irtoc.htm?lsayear=14&lsadoc=289&view=list&ldn=Y

Comments
Public comments are invited and may be directed to the Medical Licensing Board of Indiana, Attention:  Michael A. Minglin, J.D., Director, 402 West Washington Street, Room W072, Indianapolis, Indiana, 46204 or by email to mminglin@pla.in.gov

Time for Public Comments
The deadline for submission of Public Comments is September 25, 2014.

Where Comments May Be Inspected
Comments may be inspected upon request during normal business hours at the offices of the Professional Licensing Agency,
402 West Washington Street, Room W072, Indianapolis, Indiana, 46204


Public Hearing

It is estimated that a public hearing will be held before the Medical Licensing Board of Indiana on September 25, 2014

at 2:00 o'clock p.m., local time.

 

Relevant Scientific and Technical Findings

Cost Benefit Analysis
Fiscal Analysis


Timetable

It is estimated that the public hearing will be held on September 25, 2014 and that the proposed rule will

be adopted at that time.  It is estimated that the filing of the proposed rule with the Indiana Register will

occur as soon as practicable following the public hearing on September 25, 2014.

 

Effective Date
It is estimated that the final rule will become effective on November 1, 2014.


The annual drug monitoring test requirements included in emergency
rule #13-495(E) are not effective until January 1, 2015.